Keywords
How to Cite
Abstract
The objective of the research was to evaluate the risk of the development of chronic kidney disease: glomerulonephritis with nephrotic syndrome by antigens of blood groups of AB0 and Rhesus (Rh) systems.
Material and methods. We examined 119 patients (76 men and 43 women) with chronic kidney disease: primary glomerulonephritis with nephrotic syndrome. The mean age of the patients was 39.65±14.16 years. The patients underwent a puncture biopsy of the kidney to verify the morphological form of the disease. A survey of 1428 healthy individuals was conducted to determine the populational distribution of blood groups phenotypes of AB0 and Rh systems.
Results. Greater probability of the development of chronic kidney disease: glomerulonephritis with nephrotic syndrome was observed in carriers of 0 Rh+ and AB Rh+ antigens. The fact was interesting that carriers of phenotype 0 Rh– were registered much less of ten in patients than in healthy individuals. This may indicate some resistance to the disease in such individuals. Greater predisposition to the development of chronic kidney disease: glomerulonephritis with nephrotic syndrome was observed in Rh-positive women with blood groups0 (χ2=6.98; р=0.008) and АВ (φ=2.32; р=0.010). The chance of the studied pathology development in Rh-positive women versus Rh-negative was in 2.19 times higher than the same ratio in men. The highest chance to contract the pathology was in Rh-positive women with groups AB and 0 versus B, in 4.49 and 4.34 times more than men, respectively.
Conclusions. Men with phenotypes A Rh– and B Rh– versus 0 Rh–, women with phenotypes AB Rh+ and 0 Rh+ versus A Rh+ and B Rh+ have the highest risk to contract the disease. Individuals of both genders with groups 0 Rh–and B Rh+ may be resistant to the development of the disease.
References
Bochkov N. P., Puzyrev V. P., Smirnikhina S. A. (2011). Klinic heskaya genetika. ClinicalGenetics. M., 592.
Arslan B., Gürkan O., Çetin B., Arslan Ö. A., Göv T., Yazıcı G. et al. (2018). Evaluationof ABO blood group sand blood-based biomarkers as a predictor of growth kinetics of renalangiomy olipoma. Int.Urol.Nephrol., 50(12), 2131–2137. https://doi.org/10.1007/s11255-018-2012-9
Capriolli T. V., Visentainer J. E. L., Sell A. M. (2017). Lack of association between Kidd blood group system and chronic kidney disease. Rev.Bras.Hematol.Hemoter., 39(4), 301–305. https://doi.org/10.1016/j.bjhh.2017.05.007
Capuzzo E., Bonfanti C., Frattini F., Montorsi P., Turdo R., Previdi M. G. et al. (2016). The relationship between ABO blood group and cardiovascular disease: Results from the Cardiorisk program. Ann.Translat.Med., 4(10), 1–5. https://doi.org/10.21037/atm.2016.03.58
DeMartino M., Waldert M., Haitel A., Schatzl G., Shariat S. F., Klatte T. (2014). Evaluationof ABO blood group as a prognostic marke rinrenal cell carcinoma (RCC). BJU Int., 113(5B), 62–66. https://doi.org/10.1111/bju.12436
Franchini M., Liumbruno G. M., Lippi G. (2016). The prognostic value of ABO blood group in cancer patients. BloodTransfus., 14(5), 434–440. https://doi.org/10.2450/2015.0164-15
Huang J. Y., Wang R., Gao Y. T., Yuan J. M. (2017). ABO blood type and therisk of cancer – Findings from the Shanghai Cohort Study. PLoS ONE, 12(9), 1–12. https://doi.org/10.1371/journal.pone.0184295
Kaminskyi V. (2019). The significance of hereditary factorin the development of chronic kidney disease (glomerulonephritis). Family Medicine, 3(83), 20–25. https://doi.org/10.30841/2307-5112.3.2019.178572
Lee C., You D., SohnM., Jeong I. G., Song C., Kwon T. et al. (2015). Prognosticvalueof ABO blood group inpatient swith renal cell carcinoma: single-institution results from a large cohort. J.CancerRes.Clin. Oncol., 141(8), 1441–1447. https://doi.org/10.1007/s00432-015-1908-3
Liu J., Zhang S., Liu M., Wang Q., Shen H., Zhang Y. (2018) Distribution of ABO/Rh blood groups and their association with hepatitis B virusinfectionin 3.8 millionChineseadults: a population-basedcross-sectionalstudy. J.Viral.Hepat., 25(4), 401-411. doi: 10.1111/jvh.12829
Markt S. C., Shui I. M., Unger R. H., Urun Y., Berg C. D., Black A. et al. (2015). ABO Blood Group Alleles and Prostate Cancer Risk: Results from the Breast and Prostate Cancer Cohort Consortium (BPC3). Prostate, 75(15), 1677–1681. doi:10.1002/pros.23035
Murkamilov I. T., Gordeev I. G., Kaliev R. R. (2016). The role of renalanemia and cardiovascular diseasein the progression of chronic glomerulonephritis. Terap.Arkhiv, 88(12), 57–61. https://doi.org/10.17116/terarkh2016881257-61
Spiezia L., Campello E., Valle F. D., Simion C., Colpo A., Simioni P. (2018). ABO blood group and the risk of post-thrombotic syndrome. Ann.Hematol., 97(6), 1057–1060. https://doi.org/10.1007/s00277-018-3255-3
Stakišaitis D., Juknevičienė M., Ulys A., Žaliūnienė D., Stanislovaitienė D., Šepetienė R. et al. (2018). AВ0 blood group polymorphismhasanimpactonpro state, kidney and bladder cancerin association with longevity. Oncol.Letters, 16(1), 1321–1331. https://doi.org/10.3892/ol.2018.8749
Sugrue D., vanHaalen H., Rai S., McEwan P. (2018). Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design. ValueinHealth, 21, 267. https://doi.org/10.1016/j.jval.2018.04.1805
Witasp A., Ekström T. J., Schalling M., Lindholm B., Stenvinkel P.,Nordfors L. (2014). How can genetics and epigenetic shelpthenephrologist improve the diagnosis and treatment of chronic kidney disease patients? Nephrol.Dial.Transplant., 29, 972–980. https://doi.org/10.1093/ndt/gfu021
Yang M., Xie J., Ouyang Y., Zhang X., Shi M., Li X. et al. (2017). ABO blood type isassociated with renaloutcomesin patients with IgAnephropathy. Oncotarget, 8(43), 73603–73612. https://doi.org/10.18632/oncotarget.20701
Zhou B., Wu N., Zhu C., Gao Y., Guo Y., Qing P. et al. (2017). ABO bloodgroupis a risk factor for coronary artery disease in patients with poor blood pressure control. Clin.Exp.Hypertens., 39(4), 366–370. https://doi.org/10.1080/10641963.2016.1267190
Zu B., You G., Fu Q., Wang J. (2017). Association between ABO Blood Groupand Riskof Congenital Heart Disease: A 6-year largecohortstudy. Sci.Reports, 7, 10–14. https://doi.org/10.1038/srep42804
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.